Objective: In osteoarthritis (OA), changes occur in both cartilage and subchondral bone. The subchondral bone plate facilitates normal cross‐talk between articular cartilage and trabecular subchondral bone, and adaptive changes in the plate due to OA may therefore disturb cross‐talk homeostasis. To investigate these changes over time, we examined the cartilage–subchondral bone interface using a combined approach of histologic analysis and in vivo microfocal computed tomography.Methods: Sixteen‐week‐old male C57BL/6 mice (n = 32) received intraarticular injections of collagenase in 1 joint to induce instability‐related OA and received saline injections in the contralateral knee joint (control joint). At 2, 4, 6, 10, and 14 weeks after injection, changes in the tibial subchondral bone plate and subchondral trabeculae were analyzed.Results: Two weeks after injection, collagenase‐injected joints had significantly more cartilage damage and osteophytosis than did control joints. Osteoclast activity directly underneath the subchondral bone plate was significantly elevated in collagenase‐injected joints compared to control joints (mean ± SEM osteoclast surface/bone surface 11.07 ± 0.79% versus 7.60 ± 0.81%), causing the plate to become thinner and creating a large increase in subchondral bone plate porosity (mean ± SEM cumulative porosity volume 0.05 ± 0.04 × 10−3 mm3 in control joints versus 2.52 ± 0.69 × 10−3 mm3 in collagenase‐injected joints). Four weeks after injection, the previously formed perforations disappeared, coinciding with a significant rise in osteoblast activity in the subchondral trabecular bone in collagenase‐injected joints compared to control joints (mean ± SEM bone formation rate/bone surface 0.62 ± 0.13 μm3/μm2 per day versus 0.30 ± 0.03 μm3/μm2 per day).Conclusion: The current study is the first to provide quantitative longitudinal data on the dynamic changes in the subchondral bone plate after OA induction. The development of plate perforations may enhance mutual interaction between subchondral trabeculae, bone marrow cells, and the articular cartilage in OA.
Background Osteoarthritis is the most frequent chronic joint disease causing pain and disability. Besides biomechanical mechanisms, the pathogenesis of osteoarthritis may involve inflammation, vascular alterations and dysregulation of lipid metabolism. As statins are able to modulate many of these processes, this study examines whether statin use is associated with a decreased incidence and/or progression of osteoarthritis. Methods Participants in a prospective population-based cohort study aged 55 years and older (n=2921) were included. x-Rays of the knee/hip were obtained at baseline and after on average 6.5 years, and scored using the Kellgren and Lawrence score for osteoarthritis. Any increase in score was defined as overall progression (incidence and progression). Data on covariables were collected at baseline. Information on statin use during follow-up was obtained from computerised pharmacy databases. The overall progression of osteoarthritis was compared between users and non-users of statins. Using a multivariate logistic regression model with generalised estimating equation, OR and 95% CI were calculated after adjusting for confounding variables. Results Overall progression of knee and hip osteoarthritis occurred in 6.9% and 4.7% of cases, respectively. The adjusted OR for overall progression of knee osteoarthritis in statin users was 0.43 (95% CI 0.25 to 0.77, p=0.01). The use of statins was not associated with overall progression of hip osteoarthritis. Conclusions Statin use is associated with more than a 50% reduction in overall progression of osteoarthritis of the knee, but not of the hip.
1 January 2011 in Journal of Shoulder and Elbow Surgery